News about "AI drug discovery "

AstraZeneca and insitro Partner on AI-Driven Drug Discovery

AstraZeneca has collaborated with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases.

AI Drug Discovery | 16/10/2026 | By News Bureau

Ono Pharma Enters into Drug Discovery Partnership with Aitia in Neurological Diseases

Ono Pharma partners with Aitia to use causal Artificial Intelligence (AI) and Gemini Digital Twins for novel drug target discovery in neurological diseases.

AI Drug Discovery | 03/09/2026 | By News Bureau

Chai Discovery Collaborates with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery

Chai Discovery and Bristol Myers Squibb partner to advance Artificial Intelligence (AI)-driven antibody discovery, leveraging Chai’s molecular folding and design models to identify antibody candidates.

AI Drug Discovery | 21/08/2026 | By News Bureau |  148

Insilico Medicine to Present ISM6331 Phase 1 Data at ESMO 2026

Insilico Medicine will present phase 1 data for Artificial Intelligence (AI)-designed pan-TEAD inhibitor ISM6331 at ESMO 2026 in mesothelioma and advanced solid tumors.

AI Drug Discovery | 28/07/2026 | By News Bureau |  262

Insilico Medicine and Takeda Collaborate on AI Drug Discovery

Takeda and Insilico Medicine are collaborating to advance Artificial Intelligence (AI)-powered drug discovery, leveraging the Pharma.AI platform to accelerate the development of therapeutics.

AI Drug Discovery | 02/07/2026 | By News Bureau |  184

LG AI Research Partners with D&D Pharmatech for Oral Peptide Drug Discovery

LG AI Research and D&D Pharmatech have partnered to accelerate next-generation oral peptide drug discovery using advanced AI technologies. The collaboration aims to enhance drug development efficiency and strengthen LG’s leadership in the rapidly growing AI-driven biopharmaceutical market.

AI Drug Discovery | 18/06/2026 | By News Bureau |  178

Sygnature Discovery Partners with DaltonTx to Advance AI-Driven Drug Discovery

Sygnature Discovery has partnered with DaltonTx to enhance Artificial Intelligence (AI)-enabled drug discovery capabilities, accelerating medicinal chemistry decision-making while maintaining robust data security standards to support faster and more efficient therapeutic research and development.

AI Drug Discovery | 05/06/2026 | By News Bureau |  163

Incyte and Genesis Molecular AI Expand Strategic Collaboration to Accelerate AI-Driven Drug Discovery

Incyte and Genesis Molecular AI have expanded their strategic collaboration to deploy advanced molecular AI technologies and proprietary research data, aiming to accelerate drug discovery and develop next-generation therapies through AI-powered molecular design.

AI Drug Discovery | 22/05/2026 | By News Bureau |  349

Kazia Expands Oncology Platform with First-in-Class SETDB1 Inhibitor

Kazia Therapeutics expands its oncology platform with a first-in-class SETDB1 inhibitor, leveraging an AI-driven epigenetic drug discovery engine for faster and scalable candidate development.

AI Drug Discovery | 15/04/2026 | By News Bureau |  238

Eli Lilly Eyes USD 2 Billion AI Drug Discovery Deal with Insilico Medicine

Eli Lilly is set to enter into a deal worth over USD 2 billion with Hong Kong-based Insilico Medicine to accelerate drug discovery using artificial intelligence, signaling a major push toward AI-driven pharmaceutical innovation.

AI Drug Discovery | 30/03/2026 | By Darshana |  236